Company: SXTPW
Filing Date: 2025-08-15
Form Type: PRE 14A
Source: 0001213900-25-077435
Chunk: 30

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-15
Form: PRE 14A
Chunk 30
---
 it deems necessary or prudent in its discretion, the cash and equity awards (amount and manner or method of payment) to be made to
non-employee directors for such fiscal year. In making this determination, the Compensation Committee may utilize such market standard
metrics as it deems appropriate, including, without limitation, an analysis of cash compensation paid to our peer group’s independent
directors.

The Compensation Committee has the power and discretion
to determine in the future whether non-employee directors should receive annual or other grants of options to purchase shares of common
stock or other equity incentive awards in such amounts and under such policies as the Compensation Committee may determine utilizing such
market standard metrics as it deems appropriate, including, without limitation, an analysis of equity awards granted to independent directors
of our peer group.

The following table illustrates the compensation
paid by the Company to its directors. The disclosure is provided for the fiscal year ended December 31, 2024.

<div align='center'>Director Compensation

As of December 31, 2024</div>

| Name    |     | Fees Earned or Paid in Cash 
 ($)                         |        |     | Stock  
 Awards 
 ($)    |   |     | Option Awards 
 ($)(1)        |     |     | Non-Equity Incentive Plan Compensation ($) |   |     | All Other Compensation ($) |   |     | Total 
 ($)   |        |
| Charles 
 Allen   |     |                             | 73,000 |     |        | - |     |               | 912 |     |                                            | - |     |                            | - |     |       | 73,912 |
| Cheryl  
 Xu      |     |                             | 65,000 |     |        | - |     |               | 912 |     |                                            | - |     |                            | - |     |       | 65,912 |
| Stephen 
 Toovey  |     |                             | 70,000 |     |        | - |     |               | 912 |     |                                            | - |     |                            | - |     |       | 70,912 |
| Paul    
 Field   |     |                             | 70,000 |     |        | - |     |               | 912 |     |                                            | - |     |                            | - |     |       | 70,912 |

| (1) | Represents the aggregate grant                                                                             
 date fair value of options granted during the fiscal year,